利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

30 条记录 (耗时 0.04 秒)

    5-membered ring compounds
    7.
    发明授权
    5-membered ring compounds 失效
    5元环化合物

    公开(公告)号：US06380262B1

    公开(公告)日：2002-04-30

    申请号：US09762265

    申请日：2001-02-06

    申请人： Eiji Kobayashi ,  Hiromu Ohnogi ,  Nobuto Koyama ,  Katsushige Ikai ,  Hiroaki Sagawa ,  Ikunoshin Kato

    发明人： Eiji Kobayashi ,  Hiromu Ohnogi ,  Nobuto Koyama ,  Katsushige Ikai ,  Hiroaki Sagawa ,  Ikunoshin Kato

    IPC分类号： A61K3112

    CPC分类号： C07K5/0215 ,  A61K38/00

    摘要： 5-Membered ring compounds represented by general formula (I), optically active isomers thereof or salts of the same. These compounds have physiological activities including a carcinostatic effect. In said formula the bond shown by the dotted line in the 5-membered ring represents that this 5-membered ring may be either a cyclopentene ring having a double bond or a saturated cyclopentane ring, and when the 5-membered ring is a cyclopentene ring, X is OR1, Y is ═O and Z is H, and when it is a cyclopentane ring, X is ═O, Y is OR2 and Z is OR3, (wherein R1 is R4 or —(CO)—R5; R2 is H, —R6 or —(CO)—R7; and R3 is H, R8 or (CO)—R9 (wherein R4, R5, R6, R7, R8 and R9 are the same or different and each represents an aliphatic, aromatic or aliphatic aromatic group, and R5, R7 and R9 may be each H), provided that the case where R2═R3═H is excluded); and W represents a residue obtained by eliminating SH from an SH-containing compound.

    摘要翻译： 由通式（I）表示的5-元环化合物，其旋光异构体或其盐。 这些化合物具有包括致癌作用的生理活性。 在所述式中，五元环中虚线所示的键表示该5元环可以是具有双键或饱和环戊烷环的环戊烯环，当5元环为环戊烯环时 X为OR 1，Y为= O且Z为H，当为环戊烷环时，X为= O，Y为OR 2，Z为OR 3，（其中R1为R4或 - （CO）-R5; R2为 H，-R6或 - （CO）-R7; R3为H，R8或（CO）-R9（其中R4，R5，R6，R7，R8和R9相同或不同，各自表示脂族，芳族或 脂族芳族基团，R 5，R 7和R 9可以各自为H），条件是排除R2 = R3 = H的情况）; W表示通过从含SH化合物中除去SH而得到的残基。

    Remedies
    8.
    发明授权
    Remedies 失效
    补救措施

    公开(公告)号：US07268160B2

    公开(公告)日：2007-09-11

    申请号：US10182193

    申请日：2001-01-26

    申请人： Hiromu Ohnogi ,  Masahiro Shiraga ,  Eiji Kobayashi ,  Tuo-Ping Li ,  Suzu Deguchi ,  Eiji Nishiyama ,  Hiroaki Sagawa ,  Ikunoshin Kato

    发明人： Hiromu Ohnogi ,  Masahiro Shiraga ,  Eiji Kobayashi ,  Tuo-Ping Li ,  Suzu Deguchi ,  Eiji Nishiyama ,  Hiroaki Sagawa ,  Ikunoshin Kato

    IPC分类号： A61K31/35 ,  A61K31/22 ,  C07D307/02 ,  C07C67/02

    CPC分类号： A61K31/7004 ,  A23L33/10 ,  A61K31/12 ,  A61K31/216 ,  A61K31/222 ,  A61K31/352

    摘要： The present invention provides a therapeutic agent or prophylactic agent for a disease that requires enhancement of nerve growth factor production, an enhancer for nerve growth factor production, or a food, beverage or feed for enhancing nerve growth factor production, each comprising as an effective ingredient a specified compound or a salt thereof having enhancing activity for nerve growth factor production; a method for enhancing nerve growth factor production, comprising administering to a mammal the above-mentioned compound or a salt thereof; and use of the above-mentioned compound or a salt thereof in the preparation of a therapeutic agent or prophylactic agent for a disease that requires enhancement of nerve growth factor production, an enhancer for nerve growth factor production, or a food, beverage or feed for enhancing nerve growth factor production. In addition, the present invention provides novel compounds having enhancing activity for nerve growth factor production.

    摘要翻译： 本发明提供了需要增强神经生长因子产生的疾病的治疗剂或预防剂，用于神经生长因子产生的增强剂或用于增强神经生长因子产生的食品，饮料或饲料，其各自包含作为有效成分 具有增强神经生长因子生成活性的特定化合物或其盐; 一种用于增强神经生长因子产生的方法，包括向哺乳动物施用上述化合物或其盐; 以及上述化合物或其盐在制备需要增强神经生长因子产生的疾病的治疗剂或预防剂，用于神经生长因子产生的增强剂或食品，饮料或饲料中的用途 增强神经生长因子的产生。 此外，本发明提供了具有增强神经生长因子产生活性的新型化合物。